Switch to:
Onyx Pharmaceuticals, Inc. (NAS:ONXX)
Additional Paid-In Capital
$1,882.1 Mil (As of Jun. 2013)

Onyx Pharmaceuticals, Inc.'s quarterly additional paid-in capital increased from Dec. 2012 ($1,471.6 Mil) to Mar. 2013 ($1,845.7 Mil) and increased from Mar. 2013 ($1,845.7 Mil) to Jun. 2013 ($1,882.1 Mil).

Onyx Pharmaceuticals, Inc.'s annual additional paid-in capital increased from Dec. 2010 ($1,238.2 Mil) to Dec. 2011 ($1,289.1 Mil) and increased from Dec. 2011 ($1,289.1 Mil) to Dec. 2012 ($1,471.6 Mil).


Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Onyx Pharmaceuticals, Inc. Annual Data

AdditionalPaidInCapital 277.6431.0569.8661.4904.5950.61,207.01,238.21,289.11,471.6

Onyx Pharmaceuticals, Inc. Quarterly Data

AdditionalPaidInCapital 1,249.81,264.01,274.61,289.11,304.31,333.91,440.01,471.61,845.71,882.1
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)